Anti-IL6R mAb (Tiziana Life Sciences)

N/A

Report date: 2024/06/19 17:22:10

Base Information

Drug NameAnti-IL6R mAb (Tiziana Life Sciences)
Drug Alias NameTZLS-501NI-1201
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human
Mechanisms of ActionAnti-IL-6 receptor
TargetsIL-6 receptor
Therapy Area/IndicationsInflammationRespiration Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesLight Chain Bioscience Ltd
China Registration ClassN/A

Develop Information

Active CompaniesTiziana Life Sciences LtdTiziana Life Sciences Plc
Inactive CompaniesN/A
Active IndicationsInflammationRespiration Disorders
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A